Give your opinion on genetically modified vaccines to treat hepatitis B
November 30, 2021
The FPS Public Health and FAMHP would like to invite you to take part in the public consultation on a clinical trial testing the genetically modified vaccines ChAd155-hIi-HBV and MVA-HBV for the treatment of infections with the hepatitis B virus (HBV). The public consultation will run from 27 November 2021 to 27 December 2021.
Source: FAMHP
For each clinical trial application related to the use of genetically modified organisms, the government organises a thirty-day public consultation, in accordance with the Royal Decree of 21 February 2005. As a citizen, you can share your opinion on the clinical trial application with the genetically modified vaccines ChAd155-hIi-HBV and MVA-HBV for the treatment of HBV infection.